Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities - Concepedia

Concepedia

Publication | Closed Access

Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities

14

Citations

24

References

2019

Year

Daiki Taguchi, Masahiro Inoue, Koji Fukuda, Taichi Yoshida, Kazuhiro Shimazu, Kazuma Fujita, Hiroyuki Okuyama, Nobuhisa Matsuhashi, Akihito Tsuji, Kazuhiro Yoshida,

International Journal of Clinical Oncology

Therapeutic Drug MonitoringPharmaceutical ScienceMedicineTopical DrugSkin ToxicitiesDrug MonitoringPharmacotherapyToxicologyDermatologyMetabolite M5PharmacologyDrug DiscoveryDrug Resistance

References

	Year	Citations

Page 1

Page 1